Tests a program to sustain diabetic eye screening by video in rural clinics
Tests I-SITE, a program using remote eye imaging, in adults with diabetic retinopathy.
Plain-language title generated from the registry record
Registry title: I-TRUST: Implementation of Teleophthalmology in Rural Health Systems Study
Key facts
- Where
- Madison, United StatesSee the site
Where in United States
- UW School of Medicine and Public HealthMadison, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Wisconsin, Madison
- Trial code
- NCT05254535
- Record updated
- 15 May 2026
- Original description
This pragmatic clinical trial is being conducted to test the effectiveness of I-SITE (Implementation for Sustained Impact in Teleophthalmology), an implementation program to sustain increased diabetic eye screening rates using teleophthalmology in rural, multi-payer health systems. Up to 10 rural health systems providing teleophthalmology to 10,000 patients with diabetes and 100 clinical care personnel participating in the I-SITE intervention will be enrolled for up to 48 months.Read full original descriptionShow less
I-TRUST: Implementation of Teleophthalmology in Rural Health Systems Study
This pragmatic clinical trial is being conducted to test the effectiveness of I-SITE (Implementation for Sustained Impact in Teleophthalmology), an implementation program to sustain increased diabetic eye screening rates using teleophthalmology in rural, multi-payer health systems. Up to 10 rural health systems providing teleophthalmology to 10,000 patients with diabetes and 100 clinical care personnel participating in the I-SITE intervention will be enrolled for up to 48 months.
Inclusion: Health system serves rural patients as defined as those patients living in counties considered rural by the federal Office of Management and Budget (OMB); Health system has an active clinical teleophthalmology program providing diabetic eye screening in primary care prior to study randomization; Health system agrees to share de-identified patient data at the requested time intervals.
Exclusion: Health system does not serve a rural patient population; Health system has a diabetic eye screening rate of greater than 50% (e.g., above the national average) as it may limit the ability to measure improvement from I-SITE.